К содержанию
Dr. Tara EinullaevaMedical oncologist

Cancer glossary

Triple-negative breast cancer: what it means and how it is treated

Triple-negative cancer is a breast cancer subtype without ER, PR and HER2. Why it needs a different approach, why BRCA testing matters and which treatment is used.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026

In short

Triple-negative breast cancer is a subtype in which all three targets are negative on IHC: the estrogen receptor (ER), the progesterone receptor (PR) and HER2. It accounts for about 10–15% of breast cancers.

How it appears in your report

  • ‘ER 0, PR 0, HER2 0 (or 1+) — triple-negative phenotype’.
  • ‘ER-low (1–10%)’ — a borderline situation that often behaves more like triple-negative.
  • ‘HER2 1+ / 2+ FISH-negative’ — HER2-low, see HER2-low.

What it means

According to the American Cancer Society, triple-negative cancer is more common in women under 40, in Black women and in carriers of a BRCA1 mutation. It grows and spreads faster and more often comes back in the first years after treatment.

Because hormone therapy and anti-HER2 drugs don't work, chemotherapy is the backbone of treatment. With a tumor over 1–2 cm or involved lymph nodes it usually starts before surgery, together with the immunotherapy drug pembrolizumab. A complete response (pCR) is a strong favorable prognostic sign.

Does it affect treatment

Yes, directly. Everyone with triple-negative cancer should discuss testing for inherited BRCA mutations: it decides PARP inhibitors and the approach for relatives. In metastatic cancer, PD-L1 and HER2-low are checked — for immunotherapy and antibody–drug conjugates.

Questions to ask your doctor

  • Will we start with chemotherapy before surgery?
  • Do I need pembrolizumab?
  • Has a BRCA test been done — and do my relatives need one?

Sources

  1. Triple-negative Breast Cancer — American Cancer Society
  2. Pembrolizumab — National Cancer Institute
  3. Chemotherapy for Breast Cancer — National Cancer Institute

FAQ

Related terms

This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.

Related articles

All blog articles